Bank of New York Mellon’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bank of New York Mellon’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,383	Closed	-$201K	–	4584
2022 Q1	$201K	Sell	4,383 -2,762	-39%	-$132K	﹤0.01%	4236
2021 Q4	$438K	Sell	7,145 -4,914	-41%	-$340K	﹤0.01%	3885
2021 Q3	$901K	Sell	12,059 -235	-2%	-$19.7K	﹤0.01%	3448
2021 Q2	$1.14M	Buy	12,294 +5,417	+79%	+$461K	﹤0.01%	3324
2021 Q1	$610K	Buy	6,877 +3,305	+93%	+$328K	﹤0.01%	3578
2020 Q4	$333K	Buy	+3,572	New	+$285K	﹤0.01%	3787
2020 Q2	–	Sell	-6,875	Closed	-$215K	–	4086
2020 Q1	$215K	Buy	+6,875	New	+$230K	﹤0.01%	3724
2019 Q4	–	Sell	-10,000	Closed	-$295K	–	4181
2019 Q3	$295K	Buy	+10,000	New	+$325K	﹤0.01%	3781

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Bank of New York Mellon's ARKG Position: Q2 2022 in Review

Bank of New York Mellon sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,383 shares — an estimated $201K sold.

Bank of New York Mellon first reported a position in ARKG in Q3 2019 and held it in 8 quarters. The position peaked at $1.14M in Q2 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Bank of New York Mellon reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Bank of New York Mellon sold 4,383 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $201K.
Bank of New York Mellon first reported a position in ARK Genomic Revolution ETF in Q3 2019 and held it in 8 quarters.
Bank of New York Mellon's ARK Genomic Revolution ETF position peaked at $1.14M in Q2 2021.
334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.